Palvella Therapeutics, Inc.(PVLA US)
$160.86-1.430.88%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 18.7 | -17.4 | -41.7 | -43.6 | |||||
| Depreciation & Amortization | - | - | - | - | |||||
| Stock Based Compensation | 0.6 | 0.8 | 6.4 | 7.7 | |||||
| Change in Working Capital | -3.1 | -0.2 | 3.8 | 4.4 | |||||
| Other Non-Cash Items | -29.8 | 6.0 | 6.5 | 2.4 | |||||
| Net Cash from Operating Activities | -13.7 | -10.8 | -25.0 | -29.1 | |||||
| -Investments in Property, Plant & Equipment | - | - | - | - | |||||
| -Acquisitions Net | - | - | - | - | |||||
| -Purchases of Investments | - | - | - | -55.4 | |||||
| Sales/Maturities of Investments | - | - | - | - | |||||
| Other Investing Activities | - | - | - | - | |||||
| Net Cash from Investing Activities | - | - | - | -55.4 | |||||
| Net Debt Issuance | - | 78.4 | - | - | |||||
| Net Stock Issuance | - | - | 0.8 | 231.7 | |||||
| -Net Dividends Paid | - | - | - | - | |||||
| Other Financing Activities | 5.0 | 8.7 | -1.4 | -16.4 | |||||
| Net Cash from Financing Activities | 5.0 | 87.1 | -0.7 | 215.3 | |||||
| Effect of Forex Changes | - | 0.0 | 0.0 | 0.0 | |||||
| Net Change in Cash | -8.7 | 76.3 | -25.6 | 130.8 | |||||
| Cash at End of Period | 7.4 | 83.6 | 58.0 | 398.4 | |||||
| Operating Cash Flow | -13.7 | -10.8 | -25.0 | -29.1 | |||||
| -Capital Expenditure | - | - | - | - | |||||
| Free Cash Flow | -13.7 | -10.8 | -25.0 | -29.1 | |||||
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 18.7 | -17.4 | -41.7 | -43.6 | |||||
| Depreciation & Amortization | - | - | - | - | |||||
| Stock Based Compensation | 0.6 | 0.8 | 6.4 | 7.7 | |||||
| Change in Working Capital | -3.1 | -0.2 | 3.8 | 4.4 | |||||
| Other Non-Cash Items | -29.8 | 6.0 | 6.5 | 2.4 | |||||
| Net Cash from Operating Activities | -13.7 | -10.8 | -25.0 | -29.1 | |||||
| -Investments in Property, Plant & Equipment | - | - | - | - | |||||
| -Acquisitions Net | - | - | - | - | |||||
| -Purchases of Investments | - | - | - | -55.4 | |||||
| Sales/Maturities of Investments | - | - | - | - | |||||
| Other Investing Activities | - | - | - | - | |||||
| Net Cash from Investing Activities | - | - | - | -55.4 | |||||
| Net Debt Issuance | - | 78.4 | - | - | |||||
| Net Stock Issuance | - | - | 0.8 | 231.7 | |||||
| -Net Dividends Paid | - | - | - | - | |||||
| Other Financing Activities | 5.0 | 8.7 | -1.4 | -16.4 | |||||
| Net Cash from Financing Activities | 5.0 | 87.1 | -0.7 | 215.3 | |||||
| Effect of Forex Changes | - | 0.0 | 0.0 | 0.0 | |||||
| Net Change in Cash | -8.7 | 76.3 | -25.6 | 130.8 | |||||
| Cash at End of Period | 7.4 | 83.6 | 58.0 | 398.4 | |||||
| Operating Cash Flow | -13.7 | -10.8 | -25.0 | -29.1 | |||||
| -Capital Expenditure | - | - | - | - | |||||
| Free Cash Flow | -13.7 | -10.8 | -25.0 | -29.1 | |||||